If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSynectics Regulatory News (SNX)

Share Price Information for Synectics (SNX)

Share Price is delayed by 15 minutes
Get Live Data
200.00    0.00 (0.00%)
Bid:
195.00
Ask:
205.00
Spread: 10.00 (5.128%)
Market Cap: £34.01m
SNX Live PriceLast checked at - London Stock Exchange

Intraday Synectics Share Chart

Full Year Trading Update

17 Dec 2025 07:00

RNS Number : 8347L
Synectics PLC
17 December 2025
 

17 December 2025

 

 

 

Synectics plc

("Synectics" or the "Company" or the "Group")

 

Full Year Trading Update

 

Synectics plc (AIM: SNX), a leader in advanced security and surveillance solutions, provides an update on trading for the year ended 30 November 2025 ("FY 2025").

 

FY 2025 Update

 

The Group has delivered a solid performance in FY 2025, reflecting continued momentum across core markets and the successful delivery of a significant contract in the leisure and hospitality sector.

 

Revenue for the year is expected to be approximately £68 million (FY 2024: £55.8 million), with adjusted* EBITDA of £8.5 million (FY 2024: £6.3 million) and adjusted* PBT of no less than £6.0 million (FY 2024: £4.7 million). This performance includes the delivery of a significant, non-recurring gaming contract in South-East Asia, previously highlighted in the Group's interim results, which contributed approximately £12 million to FY 2025 revenue.

 

As at 30 November 2025, the Group had an order book of approximately £26.5 million (31 May 2025: £35.1 million; 30 November 2024: £38.5 million). The change in order book from the prior year end predominantly reflects the completion of the significant gaming contract which had previously been included in this figure, as well as some impact from global economic conditions delaying the timing of certain project approvals, particularly in oil and gas.

 

At 30 November 2025, the Group had a record cash balance of £14.1 million (31 May 2025: £12.1 million; 30 November 2024: £9.6 million). This strong position provides the Group with the ability to fund its investment programme and continue exploring selective acquisition opportunities aligned with its strategic priorities.

 

Reflecting the Board's continued confidence in the business' prospects, an increased final dividend of 2.8 pence per share (FY 2024: 2.5p) is recommended, giving an increased total dividend up 11% to 5.0 pence per share (FY 2024: 4.5p).

 

Strategic Progress and Outlook

 

In its FY 2024 results, Synectics outlined a refreshed strategy to align long-term objectives, accelerate growth and position the Group for long-term value creation. Throughout FY 2025, the Group has made positive initial progress on this strategy, which has evolved into a business-wide transformation, transitioning from a bespoke, project-led model to a scalable, product-led software platform with defined sector focus and partner centric global reach. As part of this progress, key leadership roles have been appointed to support delivery and execution. This strategy will drive higher margin growth, improve the quality of revenue and scale the business in a sustainable way.

 

Looking ahead, the Group enters FY 2026 with a solid order book and growing momentum in strategic execution. FY 2026 will reflect the absence of the one-off gaming contract delivered in FY 2025; however, the Group continues to see solid demand and has good visibility on its new business pipeline. Recent contract wins in the renewables and decarbonisation sectors reflect early traction from the Company's strategic initiatives to broaden its market reach and diversify its end markets.

 

As previously highlighted in the Group's interim results and the 16 October 2025 trading update, increased investment is anticipated in line with the Group's long-term growth priorities, funded from existing cash resources, as the Group executes its strategic transformation and continues to build the capabilities required to scale.

 

Given the evolving nature of this transformation, a more detailed view of FY 2026 and future year expectations will be provided alongside the full year results in March 2026. The Board remains confident in Synectics' strategy and prospects.

 

Amanda Larnder, Chief Executive Officer, commented:

"FY 2025 has been a positive year for Synectics, with the delivery of a solid financial performance and strong early progress on the strategic transformation of the business. We are focussed on aligning Synectics to the scale of the opportunity ahead - building a more scalable, product-led software platform business with stronger technology, a clearer go-to-market model, and a structured partner ecosystem.

 

We enter FY 2026 with a solid order book, a robust balance sheet, growing traction across our core and emerging markets and real momentum in delivering our strategy. I am confident that the changes we are making now will deliver long-term growth and stakeholder value creation."

 

*before share-based payment charge and exceptional items

 

For further information, please contact:

 

Synectics plc

Amanda Larnder, Chief Executive Officer

Paul Williams, Chief Financial Officer

email: info@synecticsplc.com

Tel: +44 (0) 114 280 2828

www.synecticsplc.com

 

 

Singer Capital Markets

Tel: +44 (0) 20 7496 3000

Jen Boorer / James Fischer / Patrick Weaver

Vigo Consulting  

Jeremy Garcia / Fiona Hetherington / Peter Jacob

synectics@vigoconsulting.com

Tel: +44 (0) 20 7390 0230

 

About Synectics plc

 

Synectics plc (AIM: SNX) is a leader in advanced security and surveillance solutions that help protect people, property and assets around the world.

 

It transforms customer operations by seamlessly integrating systems, technologies, and data into a unified solution-enhancing safety, improving efficiency, and enabling smarter, faster decision-making and response capabilities.

 

With its technical expertise, decades of experience, and strong partnerships, Synectics sets itself apart by delivering innovation and service that drive real value and long-term success.

 

Find out more at www.synecticsplc.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTKZMMZNVZGKZM
Date   Source Headline
10th May 20119:53 amRNSHolding(s) in Company
5th May 20113:17 pmRNSResult of AGM
4th May 20117:00 amRNSAGM Statement
15th Apr 201110:00 amRNSHolding(s) in Company
8th Apr 20113:39 pmRNSDirector Shareholding
7th Apr 20117:00 amRNSAGM - Date Change
30th Mar 20114:35 pmRNSAvailability of Report & Accounts
8th Mar 20117:00 amRNSRe: 2009 Group Executive Shared Ownership Plan
4th Mar 20117:00 amRNSPreliminary Results
1st Feb 201111:06 amRNSNotification of Results
7th Jan 20114:02 pmRNSHolding(s) in Company
4th Jan 20117:00 amRNSAcquisition
21st Dec 201010:45 amRNSHolding(s) in Company
21st Dec 20107:00 amRNSHolding(s) in Company
16th Dec 20107:00 amRNSChange of Adviser
6th Dec 20107:00 amRNSPost Year End Trading Update
27th Jul 20107:00 amRNSInterim Results
3rd Feb 20107:00 amRNSInterim Results
21st Jan 201010:36 amRNSContract Win
15th Jan 20102:59 pmRNSREPLACEMENT: Notice of Results
15th Jan 201010:35 amRNSNotice of Results
11th Nov 200910:59 amRNSResult of AGM
5th Nov 20097:00 amRNSTrading Update
9th Sep 20097:00 amRNSPreliminary Results
16th Jun 20097:00 amRNSStructural and Strategic Reorganisation
4th Feb 20097:00 amRNSInterim Results
16th Jan 200912:06 pmRNSNotification of Results
3rd Sep 20087:00 amRNSPreliminary Results
6th Feb 20087:01 amRNSInterim Results
16th Jan 20087:00 amRNSNotification of Results
6th Dec 20071:09 pmRNSCanc of AIM trading facility
6th Dec 20079:56 amRNSOffer Update
30th Nov 20077:01 amRNSOffer Update
29th Nov 20077:01 amRNSOffer Update
26th Nov 200712:34 pmRNSResult of EGM
23rd Nov 20079:57 amRNSRule 8.1- Synexus
19th Nov 20079:40 amRNSRule 8.1- Synexus
16th Nov 200710:00 amRNSRule 8.1- Synexus
15th Nov 20073:00 pmBUSRule 8.3 - Synexus Clinincal Research Plc
15th Nov 200712:07 pmBUSRule 8.3 - Synexus Clinical Research Plc
15th Nov 20079:16 amRNSRule 8.1- Synexus
14th Nov 20073:21 pmBUSRule 8.3 - Synexus Clinical Research Plc
13th Nov 20073:16 pmBUSRule 8.3 - Synexus Clinical Research Plc
7th Nov 20074:38 pmRNSOffer Document Posted
7th Nov 20077:02 amRNSOffer for Synexus
6th Nov 20079:10 amRNSRule 8.3- Synexus
22nd Oct 200710:46 amRNSHolding(s) in Company
19th Oct 20076:21 pmRNSResponse to price movement
28th Sep 20077:02 amRNSPre Close Statement
5th Sep 20078:33 amRNSBoard Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.